Extraordinary general meeting of Summit Healthcare Acquisition Corp. s shareholders to be held on March 1, 2023 at 9:00 a.m. Eastern Time YS Biopharma is a.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million.